Kenya - English - Pharmacy and Poisons Board

bharat biotech international limited genome valley shameerpet mandal hyderabad andhra - purified bulk of rh-epidermal growth factor - gel - 150 g/ gm of gel - other dermatological preparations

Kenya - English - Pharmacy and Poisons Board

bharat biotech international limited genome valley shameerpet mandal hyderabad andhra - purified bulk of rh-epidermal growth factor - gel - 60 g/ gm of gel - other dermatological preparations

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - afatinib - carcinoma, non-small-cell lung - antineoplastic agents - giotrif as monotherapy is indicated for the treatment ofepidermal growth factor receptor (egfr) tki-naïve adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating egfr mutation(s);locally advanced or metastatic nsclc of squamous histology progressing on or after platinum-based chemotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - amivantamab, quantity: 350 mg - injection, concentrated - excipient ingredients: methionine; disodium edetate; histidine; polysorbate 80; histidine hydrochloride monohydrate; water for injections; sucrose - rybrevant has provisional approval for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that has an activating epidermal-growth factor receptor (egfr) exon 20 insertion mutation, whose disease has progressed on or after platinum-based chemotherapy.,the decision to approve this indication has been made on the basis of objective response rate and duration of response in a single arm study. continued approval of this indication depends on verification and description of benefit in a confirmatory study.

Israel - English - Ministry of Health

boehringer ingelheim israel ltd. - nevirapine - tablets - nevirapine 200 mg - nevirapine - nevirapine - for use in combination with other antiretroviral agents for the treatment of hiv-1 infection.

Israel - English - Ministry of Health

boehringer ingelheim israel ltd. - nevirapine anhydrous (as hemihydrate) - suspension - nevirapine anhydrous (as hemihydrate) 50 mg / 5 ml - nevirapine - nevirapine - for use in combination with other antiretroviral agents for the treatment of hiv-1 infection.

Israel - English - Ministry of Health

taro international ltd, israel - piroxicam as beta-cyclodextrin - tablets - piroxicam as beta-cyclodextrin 20 mg - piroxicam - piroxicam - piroxicam is indicated for symptomatic relief of osteoarthritis rheumatoid arthritis or ankylosing spondylitis. when an nsaid is indicated piroxicam should be considered as a second line option. the desicion to prescribe piroxocam should be based on an assesment of the individual's patient overall risk.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - lamotrigine - oral tablet - 200mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

arrow generics ltd - lamotrigine - oral tablet - 50mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

arrow generics ltd - lamotrigine - oral tablet - 200mg